Hysteroscopic surgery
Conditions
Interventions
Group 1:Induction by general anesthesia with 0.1 mg/kg rimazolam.
Group 2:Induction by general anesthesia with 0.2 mg/kg rimazolam.
Group 3:Induction by general anesthesia with 0.3 mg/kg rimazolam.
Group 4:Induction by general anesthesia with 0.4 mg/kg rimazolam.
Sponsors
Hangzhou Women's Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-60 years who underwent hysteroscopic surgery; 2. ASA I-II level; 3. Body mass index (BMI) 18-30 kg/m2; 4. Sign the informed consent form, be able to accept the experimental method, and volunteer as a subject.
Exclusion criteria
Exclusion criteria: 1. Hypersensitivity to remimazolam or contraindications to the use of remimazolam; 2. Preoperative disturbance of consciousness or long-term use of analgesics, psychotropic drugs, and alcohol abusers with chronic pain; 3. Sedatives, antiemetics, antipruritic drugs or monoamine oxidase inhibitors or antidepressants were used within 15 days before the operation; 4. Any history of abnormal upper airway airway management or respiratory insufficiency or sleep apnea that may lead to dyspnea.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bispectral index, BIS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation score;Blood pressure;Heart rate; | — |
Countries
China
Contacts
Public ContactXiaodong Huang
Hangzhou Women's Hospital
Outcome results
None listed